CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Neurotrope, Inc.  (NTRP)
Other Ticker:  
 
 

NTRP's Revenue Growth by Quarter and Year

Neurotrope,'s Revenue results by quarter and year




NTRP Revenue (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December - - - -
III Quarter September 0.00 - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -



NTRP Revenue third quarter 2018 Y/Y Growth Comment
Neurotrope, Inc. in the third quarter recorded of $ 0.00 millions.

According to the results reported in the third quarter, Neurotrope, Inc. achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Neurotrope, Inc.' s Revenue no change of % ranks overall at the positon no. in the third quarter.




NTRP Revenue ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Neurotrope,'s third quarter 2018 Revenue $ 0.00 millions NTRP's Income Statement
Neurotrope,'s third quarter 2017 Revenue $ 0.00 millions Quarterly NTRP's Income Statement
New: More NTRP's historic Revenue Growth >>


NTRP Revenue (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Revenue third quarter 2018 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue third quarter 2018 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Neurotrope,'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NTRP's III. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NTRP's III. Quarter Q/Q Revenue Comment


Neurotrope,'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
12 Months Ending
(Sep 30 2017)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #




Cumulative Revenue growth Comment
In the Sep 30 2018 period, Neurotrope,'s cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Neurotrope, Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Sep 30 2018 period, Neurotrope,'s cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Neurotrope, Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NTRP's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for NTRP's Competitors
Revenue Growth for Neurotrope,'s Suppliers
Revenue Growth for NTRP's Customers

You may also want to know
NTRP's Annual Growth Rates NTRP's Profitability Ratios NTRP's Asset Turnover Ratio NTRP's Dividend Growth
NTRP's Roe NTRP's Valuation Ratios NTRP's Financial Strength Ratios NTRP's Dividend Payout Ratio
NTRP's Roa NTRP's Inventory Turnover Ratio NTRP's Growth Rates NTRP's Dividend Comparisons



Companies with similar Revenue no change for the quarter ending Sep 30 2018 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2018
U.s. Stem Cell, Inc. -0.17 %$ -0.175 millions
Tg Therapeutics, Inc. -0.25 %$ -0.252 millions
Alphatec Holdings, Inc. -0.42 %$ -0.420 millions
Natures Sunshine Products Inc -0.53 %$ -0.530 millions
Chemocentryx, Inc. -0.60 %$ -0.598 millions
Capital Senior Living Corp -1.42 %$ -1.422 millions
Anika Therapeutics, Inc. -1.46 %$ -1.460 millions
Heska Corp -1.51 %$ -1.505 millions
Quest Diagnostics Inc -2.18 %$ -2.175 millions
Luminex Corp -2.28 %$ -2.281 millions
Avinger Inc -2.46 %$ -2.463 millions
Invacare Corporation -2.53 %$ -2.530 millions
Lemaitre Vascular Inc -2.65 %$ -2.647 millions
Birner Dental Management Services Inc -2.72 %$ -2.723 millions
Shineco, Inc. -2.82 %$ -2.822 millions
Allergan Plc -3.05 %$ -3.046 millions
American Shared Hospital Services -3.10 %$ -3.100 millions
Diversicare Healthcare Services, Inc. -3.38 %$ -3.379 millions
Aac Holdings, Inc. -3.67 %$ -3.669 millions
Bausch Health Companies Inc. -3.74 %$ -3.740 millions
Mylan N.v. -4.17 %$ -4.175 millions
Hca Healthcare, Inc. -4.31 %$ -4.312 millions
Radnet, Inc. -4.42 %$ -4.418 millions
Cleveland Biolabs Inc -4.57 %$ -4.572 millions
Icu Medical Inc -4.68 %$ -4.681 millions
Ocular Therapeutix, Inc. -4.78 %$ -4.780 millions
Brookdale Senior Living Inc. -4.92 %$ -4.917 millions
Infusystem Holdings, Inc -5.18 %$ -5.180 millions
Opko Health, Inc. -5.19 %$ -5.192 millions
Endo International Plc -5.26 %$ -5.264 millions


     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

EYTH's Profile

Stock Price

EYTH's Financials

Business Description

Fundamentals

Charts & Quotes

EYTH's News

Suppliers

EYTH's Competitors

Customers & Markets

Economic Indicators

EYTH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071